Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Sci ; 116(Pt 7): 1269-77, 2003 Apr 01.
Article in English | MEDLINE | ID: mdl-12615969

ABSTRACT

In A7r5 vascular smooth muscle cells, the two expressed inositol 1,4,5-trisphosphate receptor (IP(3)R) isoforms were differentially localized. IP(3)R1 was predominantly localized in the perinuclear region, whereas IP(3)R3 was homogeneously distributed over the cytoplasm. Prolonged stimulation (1-5 hours) of cells with 3 microM arginine-vasopressin induced a redistribution of IP(3)R1 from the perinuclear region to the entire cytoplasm, whereas the localization of IP(3)R3 appeared to be unaffected. The redistribution process occurred independently of IP(3)R downregulation. No structural changes of the endoplasmic reticulum were observed, but SERCA-type Ca(2+) pumps redistributed similarly to IP(3)R1. The change in IP(3)R1 localization induced by arginine-vasopressin could be blocked by the simultaneous addition of nocodazole or taxol and depended on Ca(2+) release from intracellular stores since Ca(2+)-mobilizing agents such as thapsigargin and cyclopiazonic acid could induce the redistribution. Furthermore, various protein kinase C inhibitors could inhibit the redistribution of IP(3)R1, whereas the protein kinase C activator 1-oleoyl-2-acetyl-sn-glycerol induced the redistribution. Activation of protein kinase C also induced an outgrowth of the microtubules from the perinuclear region into the cytoplasm, similar to what was seen for the redistribution of IP(3)R1. Finally, blocking vesicular transport at the level of the intermediate compartment inhibited the redistribution. Taken together, these findings suggest a role for protein kinase C and microtubuli in the redistribution of IP(3)R1, which probably occurs via a mechanism of vesicular trafficking.


Subject(s)
Calcium Channels/metabolism , Microtubules/metabolism , Muscle, Smooth, Vascular/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Animals , Arginine Vasopressin/pharmacology , Calcium Channels/drug effects , Calcium Signaling/drug effects , Calcium Signaling/physiology , Calcium-Transporting ATPases/drug effects , Calcium-Transporting ATPases/metabolism , Cell Compartmentation/drug effects , Cell Compartmentation/physiology , Cell Line , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cytoplasm/drug effects , Cytoplasm/metabolism , Down-Regulation/drug effects , Down-Regulation/physiology , Enzyme Inhibitors/pharmacology , Inositol 1,4,5-Trisphosphate Receptors , Microtubules/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/ultrastructure , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Protein Transport/drug effects , Protein Transport/physiology , Rats , Receptors, Cytoplasmic and Nuclear/drug effects , Sarcoplasmic Reticulum Calcium-Transporting ATPases , Transport Vesicles/drug effects , Transport Vesicles/metabolism
2.
J Histochem Cytochem ; 50(8): 1067-80, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12133910

ABSTRACT

Immunogold labeling of ultrathin cryosections provides a sensitive and quantitative method to localize proteins at the ultrastructural level. An obligatory step in the routine preparation of cryosections from cultured cells is the detachment of cells from their substrate and subsequent pelleting. This procedure precludes visualization of cells in their in situ orientation and hampers the study of polarized cells. Here we describe a method to sample cultured cells from a petri dish or coverslip by embedding them in a 12% gelatin slab. Subsequently, sections can be prepared in parallel or perpendicular to the plane of growth. Our method extends the cryosectioning technique to applications in studying polarized cells and correlative light-electron microscopy.


Subject(s)
Cells, Cultured/cytology , Animals , Cell Polarity , Cells, Cultured/metabolism , Cells, Cultured/ultrastructure , Fluorescent Antibody Technique , Frozen Sections , Gelatin , Hippocampus/cytology , Hippocampus/metabolism , Hippocampus/ultrastructure , Membrane Proteins/metabolism , Mice , PC12 Cells , R-SNARE Proteins , Rats , Tissue Embedding
3.
Neurobiol Aging ; 23(3): 335-48, 2002.
Article in English | MEDLINE | ID: mdl-11959395

ABSTRACT

To investigate the consequences of mutant presenilin-1 (PS-1) expression under the control of the normal PS-1 gene, a gene-targeted mouse bearing the FAD mutation P264L was made. Gene-targeted models are distinct from transgenic models because the mutant gene is expressed at normal levels, in the absence of the wild-type protein. PS-1(P264L/P264L) mice had normal expression of PS-1 mRNA, but levels of the N- and C-terminal protein fragments of PS-1 were reduced while levels of the holoprotein were increased. When crossed into Tg(HuAPP695.K670N/M671L)2576 mice, the PS-1(P264L) mutation accelerated the onset of amyloid (Abeta) deposition in a gene-dosage dependent manner. Tg2576/PS-1(P264L/P264L) mice also had Abeta deposition that was widely distributed throughout the brain and spinal cord. APP(NLh/NLh)/PS-1(P264L/P264L) double gene-targeted mice had elevated levels of Abeta42, sufficient to cause Abeta deposition beginning at 6 months of age. Abeta deposition increased linearly over time in APP(NLh/NLh)/PS-1(P264L/P264L) mice, whereas the increase in Tg2576 mice was exponential. The APP(NLh/NLh)/PS-1(P264L/P264L) double gene-targeted mouse represents an animal model that exhibits Abeta deposition without overexpression of APP.


Subject(s)
Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Amyloid beta-Peptides/biosynthesis , Amyloid beta-Protein Precursor/genetics , Gene Targeting , Membrane Proteins/genetics , Mutation/genetics , Peptide Fragments/biosynthesis , Alzheimer Disease/pathology , Amino Acid Sequence , Amino Acid Substitution/genetics , Amyloid beta-Peptides/genetics , Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/metabolism , Animals , Cell Line , Female , Gene Targeting/methods , Genotype , Humans , Membrane Proteins/biosynthesis , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Mice, Transgenic , Molecular Sequence Data , Neocortex/metabolism , Neocortex/pathology , Peptide Fragments/genetics , Peptide Fragments/metabolism , Pregnancy , Presenilin-1 , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...